Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Sep;88(5):493-500.

[Arthroscopic treatment of hematogenous infected total knee arthroplasty: 5 cases]

[Article in French]
Affiliations
  • PMID: 12399715
Free article
Review

[Arthroscopic treatment of hematogenous infected total knee arthroplasty: 5 cases]

[Article in French]
A Vidil et al. Rev Chir Orthop Reparatrice Appar Mot. 2002 Sep.
Free article

Abstract

Purpose of the study: The purpose of this retrospective study was to assess the contribution of arthroscopic treatment on hematogenous infected total knee arthroplasty.

Material and methods: Five patients were treated for hematogenous infected total knee arthroplasty. All patients had a posterior stabilized prosthesis that had been implanted without any element suggesting primary infection. Delay to infection after arthroplasty was 25 months on the average. Arthroscopic treatment included joint wash-out and synovectomy in combination with prolonged antibiotic therapy.

Results: One female patient, treated within 24 hours of the onset of infection, achieved cure without recurrence at 6 months follow-up. One other female patient died. Three patients required revision surgery after failure (two reimplantations in two procedures and one reimplantation in one procedure).

Discussion: The gravity of hematogenous infections of total knee arthroplasty is well known. Cure requires insertion of a new implant in three-quarters of the cases. Local arthroscopic treatment is not effective unless performed very early. Beyond this delay, it can at best limit local symptoms.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources